She is currently pursuing a PhD at Makerere University supported in part by a D43 training grant from the NIH awarded to the Fred Hutch Cancer Research Center in Seattle. Her research is focused on antibiotic resistance among cancer patients who become immune-compromised and develop secondary infections, particularly in people living with HIV who develop HIV-associated cancers.